tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Balance Sheet

231 Followers

Mineralys Therapeutics, Inc. Balance Sheet

Mineralys Therapeutics, Inc.'s total assets for Q4 2023 were $251.64M, a decrease of -9.34% from the previous quarter. MLYS total liabilities were $10.48M for the fiscal quarter, a -22.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 251.64M$ 114.44M$ 11.13M$ 1.49M
Total Liabilities
$ 10.48M$ 166.71M$ 5.05M$ 5.08M
Total Equity Gross Minority
$ 241.15M$ -52.27M$ 6.07M$ -3.60M
Total Capitalization
$ 241.15M$ -52.27M$ 6.07M$ -3.60M
Preferred Stock Equity
--$ 29.00M-
Capital Lease Obligations
----
Currency in USD

Mineralys Therapeutics, Inc. Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis